A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Clinical trial NCT05739383 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05739383
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-09
- Primary completion
- 2029-04-16
- Enrollment
- 14012
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.